Interviews
March 09, 2020
Vascular Disease Management spoke with Daniel Clair, MD, Chairman of the Department of Surgery for the Palmetto Health-USC Medical Group in Columbia, South Carolina. Dr Clair discussed the impact of new technologies for aortic aneurysm therapy on…
February 10, 2020
Mark Peretti, Brand Marketing Leader, Medical Product Division at W. L. Gore & Associates, Inc., discusses a new app designed to make it easier for doctors to talk to patients about procedures with the digital, visual language consumers have…
January 31, 2020
Vascular Disease Management talks with William Jordan Jr., MD, Professor of Surgery and Chief, Division of Vascular Surgery and Endovascular Therapy at Emory University School of Medicine, in Atlanta, Georgia.
January 21, 2020
Vascular Disease Management spoke with Raghu Kolluri, MD, MS, RVT, FSVM, President for the Society for Vascular Medicine and System Medical Director, Vascular Medicine at OhioHealth Riverside Methodist Hospital. Dr. Kolluri discussed challenges…
January 21, 2020
Vascular Disease Management spoke with Daniel Clair, MD, about challenges in treating aortic occlusive disease, upcoming clinical trials, and a case-based discussion at ISET.
January 17, 2020
Vascular Disease Management talks with Ali Azizzadeh, MD, Professor and Director of the Division of Vascular Surgery, Cedars-Sinai Medical Center and U.S. principal investigator for the Valiant Navion IDE study.
January 03, 2020
Lawrence Garcia, MD, discusses hypertensive therapy for CLI patients, as well as the importance of managing CLI patients from a global perspective.
December 09, 2019
Vascular Disease Management talks with IMPERIAL trial co-principal investigator William A. Gray, MD, FACC, FSCAI, System Chief, Division of Cardiovascular Disease; President, Lankenau Heart Institute, Main Line Health, Wynnewood, Pennsylvania.
November 12, 2019
Vascular Disease Management talks with Ravish Sachar, MD, FACC, University of North Carolina - Rex Hospital Physician-in-Chief for Heart and Vascular Services, and Principal Investigator of the RANGER II SFA trial.
May 21, 2019
Bret N. Wiechmann, MD, discusses current options for treatment, his personal approach to treatment decisions, and upcoming technologies to watch.
December 14, 2018
In this interview, Dr. Schermerhorn discusses the results of the TCAR (Trans-Carotid Artery Revascularization) trial, which compared TCAR with CEA in patients with carotid stenosis.
Back to Top